Government supports early-stage startups but India biotech lacks growth-stage funding
India's biotech scene is moving beyond just generics and services: think cutting-edge drugs and smart diagnostics.
But while early-stage startups are getting a boost from government programs, companies trying to launch new therapies are hitting a wall when it comes to funding bigger steps like clinical trials.
Experts urge growth-stage biotech capital
Experts say what's really missing is growth-stage funding that matches biotech's long timelines.
Mayur Sirdesai points out India needs more focused venture funds to help ideas become real products, and Amit Mookim adds that long-term capital is key for scaling up.
Even with cool partnerships happening now, building a strong ecosystem could take five to 10 years, especially in areas like cancer care and affordable health tech, unless investment in infrastructure keeps pace.